E. O. Grozina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
E. O. Grozina has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Aleksandr V. Leontiev
Moscow Clinical Scientific Center named after Loginov MHD; Moscow Financial and Industrial University “Synergy
1 shared publication - Anatoly I. Khavkin
Research Clinical Institute of Childhood; Belgorod State National Research University
1 shared publication - Andrey N. Surkov
Pediatrics and Child Health Research Institute in Petrovsky National Research Centre of Surgery; Pirogov Russian National Research Medical University
1 shared publication - I. A. Nikitina
Moscow Clinical Scientific Center named after Loginov MHD
1 shared publication - M. A. Orlyuk
SYNERGY University
1 shared publication - Yurii E. Kitsenko
I.M. Sechenov First Moscow State Medical University (Sechenov University)
1 shared publication
Latest Publications
- Open Access
- 22 January 2026
- Published by LLC Global Media Technology in Experimental and Clinical Gastroenterology
- No. 6,p. 135-141
Cellular technologies in proctology
Modern regenerative surgery is a promising interdisciplinary field based on the use of stem cells and fully functional tissue equivalents created through cellular engineering techniques. These cells can differentiate into specialized cell types and modulate inflammatory processes, offering broad potential for the repair of damaged tissues. Of particular interest are multipotent mesenchymal stromal cells (MSCs), which exhibit high plasticity. They can differentiate into various cell lineages, including adipogenic, chondrogenic, osteogenic, and myogenic, as well as pancreatic cells, hepatocytes, and neural cells. Another key tool in regenerative medicine is platelet-rich plasma (PRP). Its advantages include ease of preparation and a minimal risk of immune reactions.
- 22 January 2026
- Published by LLC Global Media Technology in Experimental and Clinical Gastroenterology
- No. 6,p. 135-141
Open AccessCellular technologies in proctology
Modern regenerative surgery is a promising interdisciplinary field based on the use of stem cells and fully functional tissue equivalents created through cellular engineering techniques. These cells can differentiate into specialized cell types and modulate inflammatory processes, offering broad potential for the repair of damaged tissues. Of particular interest are multipotent mesenchymal stromal cells (MSCs), which exhibit high plasticity. They can differentiate into various cell lineages, including adipogenic, chondrogenic, osteogenic, and myogenic, as well as pancreatic cells, hepatocytes, and neural cells. Another key tool in regenerative medicine is platelet-rich plasma (PRP). Its advantages include ease of preparation and a minimal risk of immune reactions.